1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain.

      1 , , ,
      The Journal of antibiotics

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The neurotoxicity of meropenem was much lower than that of both imipenem and panipenem after intraventricular administration to mice. To clarify the major structural features responsible for the induction of convulsions by carbapenem antibiotics, the structure-activity relationship on convulsant activity was investigated in N-acetyl-2-pyrroline and cyclopentene derivatives which correspond to the 5-membered ring containing the C-2 side chain of carbapenem antibiotics. Among these derivatives, compounds with strong basicity in the side chain showed convulsant activity similar to that of the parent carbapenem compounds. In addition to the strength of the basicity of the amino group, the distance from the carboxyl to the amino group and steric crowding around the amino group also appeared to play an important role in the induction of convulsions. The results of gamma aminobutyric acid (GABAA) receptor binding assays indicated that the induction of convulsions was caused predominantly by the inhibition of GABAA-mediated inhibitory transmission. However, the in vivo convulsant activity of some of these compounds did not correlate with their in vitro inhibitory effect on GABAA receptor binding.

          Related collections

          Author and article information

          Journal
          J. Antibiot.
          The Journal of antibiotics
          0021-8820
          0021-8820
          May 1995
          : 48
          : 5
          Affiliations
          [1 ] Development Research Laboratory I, Sumitomo Pharmaceuticals Research Center, Osaka, Japan.
          Article
          10.7164/antibiotics.48.408
          7797443
          d508e43d-66bf-4ac6-bfc2-521e1d0fdc26
          History

          Comments

          Comment on this article